OmniVis
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
OmniVis, founded in 2017 in South San Francisco and co-founded by Purdue alumna Dr. Katherine Clayton and three professors, built a smartphone-based rapid cholera detection platform. A water sample is placed in a single-use test kit and inserted into a handheld device fitted to a smartphone; the platform detects the cholera bacterium (Vibrio cholerae) in under an hour instead of the three to five days conventional lab methods take, and uploads geo-tagged results to the cloud for outbreak surveillance.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Founded
OmniVis was founded as a Purdue University-affiliated startup by Dr. Katherine Clayton and three professors, commercializing Purdue-patented technology that cuts cholera detection time from three to five days to about 30 minutes.
- Bangladesh beta test
OmniVis teamed up with the International Centre for Diarrhoeal Disease Research, Bangladesh, one of the world's leading cholera research hospitals, to beta test the smartphone cholera detection platform in the field.
- COVID-19 test development
OmniVis began developing a rapid smartphone-based COVID-19 test detecting the disease in saliva and nasal swabs, supported by the US Department of Agriculture and the National Science Foundation.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.